Atlas Trials

SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes

Clinical trial NCT07272057 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07272057
Sponsor
Shanghai Chest Hospital
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Cancer
Start date
2025-12-07
Primary completion
2026-10-07
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.